Colinz Laboratories bulk deals, insider trading and stake changes
BSE: 531210Pharmaceuticals & BiotechnologySmall Cap
Share price at the BSE close on 23 Oct 2026. Previous close ₹67.00.
- Next results date: the board meets on 29 Oct 2026 to consider: quarterly results.
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies.
- ₹17 Cr4,457th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. The filing of 30 Jul 2026
- 6.1
- P/E without one-offsPrice to earnings without one-off items. Market cap divided by core profit: the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, less one-off items (exceptional items and the result of businesses sold or closed). Shown where the one-off items move that profit by more than a tenth. The last twelve months' profit includes ₹2.76 crore of one-off items, the largest of them in the quarter to Jun 2026.
- 512.2
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. The filing of 29 Apr 2026
- 1.7
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it. The filing of 30 Jul 2026
- 28.7%
- ROE without one-offsReturn on equity without one-off items. Core profit, the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders less one-off items (exceptional items and the result of businesses sold or closed), as a percentage of the same net worth as the return on equity. Shown where the one-off items move that profit by more than a tenth. The last twelve months' profit includes ₹2.76 crore of one-off items, the largest of them in the quarter to Jun 2026.
- 0.3%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet. The filing of 30 Jul 2026
- 1.7%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026. The filing of 29 Apr 2026
- 0.04
- Volume, BSEVolume. Shares traded on the last trading day.
- 4,440
Promoter and insider buying and selling
Trades made since 23 Oct 2025.Colinz Laboratories promoter holding
No promoter, director, key manager or employee bought or sold on the market.
- Promoters and promoter group: no market trade · 2 off-market moves
- Others: no market trade · 4 off-market moves
Colinz Laboratories insider trading
All 6 disclosures on record.Insider trading, all companies
May 2026
- LIKHITTA DUGAR₹0.06 Cr11,000 sharesReceived · Designated Person · 21 May 2026 · disclosed 23 May · Off Market · held none before, holds 11,000 after, stake 0.44% after
- ANTARIKSH DUGAR₹0.06 Cr11,000 sharesReceived · Designated Person · 21 May 2026 · disclosed 23 May · Off Market · held none before, holds 11,000 after, stake 0.44% after
- ANNJANA DUGAR₹0.20 Cr40,000 sharesReceived · Designated Person · 21 May 2026 · disclosed 23 May · Off Market · held none before, holds 40,000 after, stake 1.59% after
- PADAM DUGAR₹1.58 Cr3,16,000 sharesReceived · Designated Person · 21 May 2026 · disclosed 23 May · Off Market · held none before, holds 3,16,000 after, stake 12.54% after
- VIJAYA MANI₹1.89 Cr3,78,000 sharesGave · Promoter and Director · 21 May 2026 · disclosed 23 May · Off Market · stake 49.56% before, 34.56% after
Dec 2025
- VIJAYA MANI₹3.98 Cr8,67,750 sharesReceived · Promoter · 11 Dec 2025 · Off Market · stake 15.11% before, 49.56% after
Trades by the company's promoters, directors, key managers, employees and their relatives, as each disclosed them. Value is what the filer stated; the mode is shown where the shares moved off the market.
Colinz Laboratories stake sales and purchases
All 3 disclosures on record.
May 2026
- AcquiredPadam Dugar & Others15.01% of the company3,78,000 sharesholds 15.01% after21 May 2026 · filed under the 5% rule · Off Market
- SoldVijaya Mani · promoter3,78,000 sharesholds 34.56% after21 May 2026 · filed under the 2% rule · Off Market
Dec 2025
- AcquiredVijaya Mani · promoter34.45% of the company8,67,750 sharesholds 49.56% after11 Dec 2025 · filed under the 2% rule · Transmission
The 5% rule: an investor discloses on reaching 5% of the company. The 2% rule: a holder of 5% or more discloses each change of 2% or more, including one that takes it below 5%. A transfer exempt from an open offer, the offer to buy from every other shareholder that a large purchase otherwise brings, is disclosed too. Each line shows what its filing states, which can be a smaller change than its rule names.
Colinz Laboratories bulk deals
Last 12 months, since 23 Oct 2025: 8 bulk deals, ₹0.81 Cr bought and ₹0.24 Cr sold Bought and sold in deals. Each deal's shares times its price, added up for the buyers and apart for the sellers, so a block deal, which names both, counts on each side.Today's bulk and block deals, all companies
ValueValue of a deal. The shares traded times the deal's price.Per cent of the companyPer cent of the company. The shares traded as a percentage of all the company's shares in issue on the day of the deal.
Wednesday 12 Aug 20261 firm · ₹0.11 Cr bought · ₹0 soldNet bought ₹0.11 Cr
- BoughtGOKULAM FARMSBought 13,701 at ₹81.470.54% of the company₹0.11 Cr
Thursday 9 Jul 20261 firm · ₹0.25 Cr bought · ₹0 soldNet bought ₹0.25 Cr
- BoughtDIVYA KANDABought 39,500 at ₹63.561.57% of the company₹0.25 Cr
Wednesday 1 Jul 20261 firm · ₹0.13 Cr bought · ₹0 soldNet bought ₹0.13 Cr
- BoughtBIJAL KISHORCHANDRA MADHANIBought 15,000 at ₹87.240.60% of the company₹0.13 Cr
Friday 30 Jan 20263 firms · ₹0.32 Cr bought · ₹0.24 Cr soldNet bought ₹0.08 Cr
- BoughtGAURAV AGARWALBought 16,338 at ₹84.460.65% of the company₹0.14 Cr
- Both waysBONANZA PORTFOLIO LIMITEDBought 7,000 at ₹86.94Sold 14,260 at ₹78.300.57% of the companyNet −7,260 shares₹0.06 Cr bought
- Both waysF3 ADVISORS PRIVATE LIMITEDBought 14,741 at ₹79.68Sold 14,741 at ₹85.940.59% of the companyNet nil₹0.12 Cr bought
Friday 9 May 20251 firm · ₹0.07 Cr bought · ₹0 soldNet bought ₹0.07 Cr
- BoughtKEYUR SURESHBHAI SHAHBought 13,702 at ₹53.990.54% of the company₹0.07 Cr
Wednesday 10 Jul 20241 firm · ₹0.10 Cr bought · ₹0 soldNet bought ₹0.10 Cr
- BoughtBHUPESH GUPTABought 12,731 at ₹80.980.51% of the company₹0.10 Cr
Wednesday 31 Jan 20071 firm · ₹0.02 Cr bought · ₹0.02 Cr soldNet nil
- Both waysKETAN BHAILAL SHAHBought 34,000 at ₹6.85Sold 34,000 at ₹6.85Net nil₹0.02 Cr bought
A bulk deal is one client trading half a per cent or more of the shares in a day; a block deal is a large trade in the exchange's separate block window, its buyer and its seller each on a line of their own. A firm that bought and sold the shares the same day is on one line, with its net. All 11 deals on record from 4 Jan 2004.